PubMed ID:
23782487
Public Release Type:
Journal
Publication Year: 2013
Affiliation: Section of Hepatology, Division of Gastroenterology, Hepatology and Nutrition and the Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, VA, USA.
DOI:
https://doi.org/10.1111/liv.12214
Authors:
Lee WM,
Stravitz RT,
Acute Liver Failure Study Group,
Bajaj JS,
Cheng J,
Mirshahi F,
Reisch J,
Sanyal AJ
Studies:
Acute Liver Failure Study Group: Adult Acute Liver Failure Study
N-Acetylcysteine (NAC) improves transplant-free survival in patients with non-acetaminophen acute liver failure (ALF) when administered in early stages of hepatic encephalopathy. The mechanisms of this benefit are unknown.